The new programme is dedicated to highlighting the value that the products bring to the NHS, prescribers, and patients.
The company was founded in 1998 and is committed to building and nurturing meaningful partnerships with customers in the UK and internationally.
The company is dedicated to delivering a growing portfolio of high-quality products to help improve patient outcomes at responsible prices.
The core values of the company are Integrity, Partnership, and Reliability.
The company recently introduced CEYESTO Melatonin Oral Solution in the UK, featuring a diverse set of approved indications, two of which are world-first.